within Pharmacolibrary.Drugs.ATC.S;

model S01EE03
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.25,
    Cl             = 1.5 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 0.03 / 1000000,
    adminCount     = 1,
    Vd             = 0.00067,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Bimatoprost is a synthetic prostamide analog used primarily to reduce intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. It is approved for ophthalmic use and is widely prescribed today.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers following topical ocular administration.</p><h4>References</h4><ol><li><p>Shafiee, A, et al., &amp; Hosseini, K (2013). Ocular pharmacokinetics of bimatoprost formulated in DuraSite compared to bimatoprost 0.03% ophthalmic solution in pigmented rabbit eyes. <i>Clinical ophthalmology (Auckland, N.Z.)</i> 7 1549–1556. DOI:<a href=&quot;https://doi.org/10.2147/OPTH.S48766&quot;>10.2147/OPTH.S48766</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/23940414/&quot;>https://pubmed.ncbi.nlm.nih.gov/23940414</a></p></li><li><p>Shen, J, et al., &amp; Attar, M (2017). Ocular pharmacokinetics and tolerability of bimatoprost ophthalmic solutions administered once or twice daily in rabbits, and clinical dosing implications. <i>Clinical ophthalmology (Auckland, N.Z.)</i> 11 1761–1767. DOI:<a href=&quot;https://doi.org/10.2147/OPTH.S143428&quot;>10.2147/OPTH.S143428</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/29026287/&quot;>https://pubmed.ncbi.nlm.nih.gov/29026287</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end S01EE03;
